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Abstract
BACKGROUND
To solve the problem of liver transplantation donor insufficiency, an alternative
cell transplantation therapy was investigated. We focused on amniotic epithelial
cells (AECs) as a cell source because, unlike induced pluripotent stem cells, they
are cost-effective and non-tumorigenic. The utilization of AECs in regenerative
medicine, however, is in its infancy. A general profile for AECs has not been
comprehensively analyzed. Moreover, no hepatic differentiation protocol for
AECs has yet been established. To this end, we independently compiled human
AEC libraries, purified amniotic stem cells (ASCs), and co-cultured them with
mesenchymal stem cells (MSCs) and human umbilical vein endothelial cell
(HUVECs) in a 3D system which induces functional hepatic organoids.
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AIM
To characterize AECs and generate functional hepatic organoids from ASCs and
other somatic stem cells
METHODS
AECs, MSCs, and HUVECs were isolated from the placentae and umbilical cords
of cesarean section patients. Amnion and primary AEC stemness characteristics
and heterogeneity were analyzed by immunocytochemistry, Alkaline
phosphatase (AP) staining, and flow cytometry. An adherent AEC subpopulation
was selected and evaluated for ASC purification quality by a colony formation
assay. AEC transcriptomes were compared with those for other hepatocytes cell
sources by bioinformatics. The 2D and 3D culture were compared by relative
gene expression using several differentiation protocols. ASCs, MSCs, and
HUVECs were combined in a 3D co-culture system to generate hepatic organoids
whose structure was compared with a 3D AEC sphere and whose function was
elucidated by immunofluorescence imaging, periodic acid Schiff, and an
indocyanine green (ICG) test.
RESULTS
AECs have certain stemness markers such as EPCAM, SSEA4, and E-cadherin.
One AEC subpopulation was also either positive for AP staining or expressed the
TRA-1-60 and TRA-1-81 stemness markers. Moreover, it could form colonies and
its frequency was enhanced ten-fold in the adherent subpopulation after selective
primary passage. Bioinformatics analysis of ribose nucleic acid sequencing
revealed that the total AEC gene expression was distant from those of pluripotent
stem cells and hepatocytes but some gene expression overlapped among these
cells. TJP1, associated with epidermal growth factor receptor, and MET,
associated with hepatocyte growth factor receptor, were upregulated and may be
important for hepatic differentiation. In conventional flat culture, the cells turned
unviable and did not readily differentiate into hepatocytes. In 3D culture,
however, hepatic gene expression of the AEC sphere was elevated even under a
two-step differentiation protocol. Furthermore, the organoids derived from the
MSC and HUVEC co-culture showed 3D structure with polarity, hepatic-like
glycogen storage, and ICG absorption/elimination.
CONCLUSION
Human amniotic epithelial cells are heterogeneous and certain subpopulations
have high stemness. Under a 3D co-culture system, functional hepatic organoids
were generated in a multicellular microenvironment.
Key words: 3D micropattern; Amniotic epithelial cells; Amniotic stem cells; Hepatic
differentiation; Heterogeneity; Human placental tissue; Human umbilical vein endothelial
cells; Mesenchymal stem cells; Multicellular microenvironment; Organoid
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Core tip: Amniotic stem cells were exploited as a cell source alternative to liver
transplantation therapy instead of induced pluripotent stem cells. However, they
presented with low hepatic function efficiency. We used 3D co-culture and a
combination of supportive somatic stem cells to simulate an in vivo microenvironment.
Our selected subpopulation of adherent amniotic stem cells self-organized ex vivo and
generated functional organoids. Cell selection methods and bioinformatics may help
refine the differentiation protocol.
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INTRODUCTION
Liver  cirrhosis  and  liver  failure  are  global  problems.  They  are  caused  by  viral
infections,  alcoholic-  or  non-alcoholic  steatohepatitis,  autoimmune  hepatitis,
metabolic and hereditary diseases, and others[1]. The only curative treatment is liver
transplantation. However, there is a worldwide shortage of liver donors. Moreover,
liver transplantation is associated with high mortality and morbidity and high-risk
patients with comorbidity do not meet the indication criteria[2,3]. Cell transplantation
has been proposed as an alternative therapy to whole organ transplantation. Several
cells have been investigated as hepatic cell sources. Human donor-derived hepatocyte
transplantation was attempted to cure cirrhosis and it did have some therapeutic
benefit[4,5]. However, it required many hepatocytes and failed to solve the problem of
donor insufficiency.
Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) are known
to differentiate into hepatocytes[6]. Although they have a high potential for hepatic
differentiation, there are ethical, tumorigenicity, and cost issues associated with them.
Previous reports indicated that somatic cells such as fibroblasts were induced to
differentiate into hepatocyte-like cells by direct reprogramming[7,8]. In this case, virus-
mediated overexpression of lineage-specific transcription factors was needed. Other
cell types include mesenchymal stem cells (MSCs), hematopoietic stem cells (HSCs),
menstrual blood-derived stem cells, and amniotic stem cells (ASCs)[5,9]. Somatic stem
cells require only differentiation factors but no gene editing. The latter may cause
undesirable  and unexpected side effects.  Here,  we attempted to induce ASCs to
differentiate into hepatocytes because they have several beneficial characteristics.
Amniotic epithelial cells (AECs) are easily isolated from amniotic membranes after
delivery. This process causes no harm to the donor. Embryologically, the amnion is
derived from the epiblast which can differentiate into three germ layers. Even at full
term pregnancy, this differentiation potential persists in ASCs which are an immature
subpopulation  of  AECs[10].  AECs  also  have  immune tolerance  and are  therefore
suitable for allogenic transplantation[11,12]. Furthermore, they have certain features, in
common with hepatocytes such as the expression of ALB, AAT, or CYP3A4[13].
Previous studies attempted to differentiate AECs into hepatocyte-like cells in 2D
culture[14,15]. However, no differentiation protocol was established. Without systemic
and comprehensive analyses in vivo or in vitro, AEC quality could not be verified and
it  may  have  been  unsatisfactory  and  inferior  to  ESCs  or  iPSCs[5].  Therefore,  its
functional activity would be insufficient for clinical use when a higher level of hepatic
function  was  required.  Moreover,  as  the  general  AEC  profile  had  not  yet  been
elucidated,  it  was  difficult  to  determine  which  differentiation  protocol  was
appropriate  for  AECs.  Therefore,  we  endeavored  to  clarify  AEC  stemness
characteristics, heterogeneity, and general profile by using transcriptomes. We also
tried to select an adherent subpopulation to purify ASCs.
A 3D culture system may promote and enhance stem cell differentiation potential
in co-culture with endothelial, mesenchymal, and other cells[16,17]. Here, we combined
3D culture conditions and co-culture with other somatic stem cells and supportive
stroma cells.  We attempted to simulate an in vivo-like microenvironment using a
selected subpopulation of adherent ASCs for ex-vivo self-organization and ultimately
obtained functional organoids.
MATERIALS AND METHODS
Isolation of somatic stem cells
AECs: Human placenta was acquired from the University of Tsukuba Hospital with
approval from the institutional review board (IRV code: H27-58). All samples were
collected from patients who had provided informed consent. Emergent operation
cases were excluded. The amniotic membrane was peeled off  the placenta in the
operating  room  immediately  after  birth.  After  washing  in  pre-digestion  buffer
(Hank’s balanced salt solution, HBSS; Wako Pure Chemical Industries Ltd., Osaka,
Japan) with 0.02% egtazic acid (EGTA; Wako Pure Chemical Industries Ltd., Osaka,
Japan),  the  membrane  was  incubated  in  0.05%  trypsin-EDTA  (Thermo  Fisher
Scientific, Waltham, MA, United States) at 37 °C for 20-30 min. HBSS with 10% fetal
bovine serum (FBS; Thermo Fisher Scientific, Waltham, MA, United States) was added
and gentle agitation followed to detach the epithelial cells from the membrane. The
cells were incubated with 0.05% trypsin-EDTA and washed again to collect the AECs.
A 100-µm strainer (Merck EMD, Darmstadt, Germany) was used to remove a clot
from the cell suspension and isolate primary AECs. Viability was checked with 0.4%
trypan blue dye (Dojindo Laboratories, Kumamoto, Japan) and found to be > 90%.
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Human umbilical vein endothelial cells (HUVECs): After the umbilical cords were
harvested, the umbilical veins were filled with collagenase buffer (HBSS with 0.24% 4-
(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES; Merck EMD, Darmstadt,
Germany), 0.005% trypsin inhibitor (Wako Pure Chemical Industries Ltd.,  Osaka,
Japan), and 0.05% collagenase (Worthington Biochemical Corporation, Lakewood, NJ,
United  States).  The  veins  were  incubated  at  37  °C  for  15  min.  The  buffer  was
centrifuged at 450 × g and 4 °C for 5 min to obtain a cell pellet containing HUVECs.
This pellet was seeded to a plate using an EGM Bullet Kit (Lonza, Basel, Switzerland).
In most cases, the HUVECs grew to confluence within 4 d.
MSC: After HUVEC collection, Wharton's jelly was minced and seeded to a plate with
Dulbecco’s modified Eagle’s medium and 10% FBS. Attached MSCs were isolated and
in most cases, they grew to confluence within 2 wk.
Cell culture
2D culture: For the AECs, a custom culture medium was blended and named AEC
basal medium (AECBM). The media and protocols are listed in Supplementary Figure
1. Primary AECs were used in most analyses. In the culture experiments, however,
AECs were precultured with AECBM for 5-7 d then used for differentiation. In the
present study, the multistep hepatic differentiation protocol of Nie et al[17] was applied.
In that study, iPSCs were differentiated into hepatocytes. The AEC culture medium
was changed step by step within 3 wk.
Another simple differentiation protocol from AECs to hepatocytes was reported by
Maymó  et  al[14].  In  brief,  the  cells  were  cultured  for  1  wk  in  Iscove’s  modified
Dulbecco’s medium containing epidermal growth factor (EGF) then cultured with
EGF and dexamethasone. This method was named the two-step protocol.
3D culture: A primary 2D culture was prepared to select a subpopulation of adherent
AECs. Unattached cells were removed after 72 h. A 24-well 3D micropattern culture
plate (Kuraray, Tokyo, Japan) was used for the next step. After coating the plate with
lipidure (NOF Corporation, Tokyo, Japan), the precultured AECs were seeded at a
density of 106/well. The AECs formed a sphere within 3-7 d. AECs, HUVECs, and
MSCs were used for organoid propagation and they formed spheres within 1 d.
qRT-PCR
The primers used are listed in Table 1. The TaqMan PCR protocol from Integrated
DNA Technologies, Inc. (Coralville, IA, United States) was used. In brief, the RNA
was extracted from the cultured cells with Isogen (Nippon Gene, Tokyo, Japan). Then
the isolated RNA was converted to cDNA with a Revert Aid RT kit (Thermo Fisher
Scientific, Waltham, MA, United States). The cDNA, primers, probes, reference dye,
and PrimeTime Gene Expression Master Mix (Integrated DNA Technologies, San Jose,
CA, United States) containing hot-start DNA polymerase, dNTPs, enhancers, and
stabilizers were combined. A 7500 Real-Time PCR System (Thermo Fisher Scientific,
Waltham, MA, United States) ran the PCR.
Immunofluorescence analysis
Amnion and organoids were stained with following antibodies:  Primary; SSEA4,
TRA-1-60,  TRA-1-81  (Cell  Signaling  Technology,  Danvers,  MA,  United  States),
EPCAM (BD, Franklin Lakes, NJ, United States), E-cadherin (BD, Franklin Lakes, NJ,
United States).  Frozen sample sections were fixed with 50% acetone (Wako Pure
Chemical Industries Ltd., Osaka, Japan) and 50% methanol (Wako Pure Chemical
Industries Ltd., Osaka, Japan) for 30 min.
The samples were incubated with primary antibody at 4 °C overnight, washed 3 ×,
and incubated with a fluorescence-conjugated secondary antibody for 1 h at 20-25 °C.
Before each antibody incubation, blocking was performed with 10% normal goat
serum (NGS; Merck EMD, Darmstadt, Germany). In the last step, the samples were
mounted  with  4’,6-diamidino-2-phenylindole  (DAPI;  Dojindo  Laboratories,
Kumamoto, Japan) and photographed under an All-in-One Fluorescence Microscope
(BZ-X710; Keyence, Osaka, Japan) or a confocal microscope (Leica TCS SP6; Leica
Microsystems, Wetzlar, Germany).
For live amnion staining, the amnion was incubated with anti-TRA-1-60 antibody
for 30 min at 37 °C and then with Hoechst (Dojindo Laboratories, Kumamoto, Japan)
for 15 min at 37 °C. Pictures were obtained with an Inverted System Microscope IX71
(Olympus, Tokyo, Japan).
Flow cytometry
The following antibodies and DAPI were used: SSEA4-FITC (BioLegend, San Diego,
CA, United States), TRA-1-81-PE (Thermo Fisher Scientific, Waltham, MA, United
States),  TRA-1-60-PE (Thermo Fisher Scientific,  Waltham, MA, United States),  E-
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Figure 1
Figure 1  Characteristics of human amniotic membrane and amniotic epithelial cells. A: H and E staining of amniotic membrane. Bar, 50 µm; B: AP staining of
amniotic membrane. Positive cells are indicated with arrows. Bar, 100 µm. In A and B, the amniotic membrane was rolled before embedding. Therefore, many layers
can be seen in one picture; C: Immunofluorescent staining of frozen section of amniotic membrane. Anti-SSEA4 antibody (green), E-cadherin antibody (red), and DAPI
were used; D: Same as C. Anti-TRA-1-81 antibody (green), anti-EPCAM antibody (red), and DAPI were used; E: Direct tissue staining of amniotic membrane. Anti-
TRA-1-60 antibody (green) and DAPI were used. Bars in C, D, and E represent 100 µm; F: Colonies formed from cultured amniotic epithelial cells (AECs) and
observed by phase-contrast microscopy. Bar to left of F represents 200 µm. Bar to right of F represents 500 µm; G: Frequency of colony formation from primary AECs
and adherent AECs. Cells which did not attach to the well surface were removed to purify the amniotic stem cells; H: Gene expression of primary AECs, mesenchymal
stem cells(MSCs), and induced pluripotent stem cells(iPSCs) detected by qRT-PCR; I: surface markers of primary AECs verified by flow cytometry.
cadherin-Alexa Flour 647 (BD, Franklin Lakes, NJ, United States), and EPCAM-APC
(BD, Franklin Lakes, NJ, United States). The cells were incubated with antibody on ice
for 30 min then washed twice. The cells were analyzed in FACS Jazz (BD, Franklin
Lakes,  NJ,  United States) and FlowJo v.  7.6.1 (FlowJo LCC, Ashland, CO, United
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Table 1  List of primers
Name Primer sequence
SOX2 F TGCACCGCTACGACGTGA
R GGAGCCAAGAGCCATGCC
NANOG F TGCTGAGATGCCTCACACG
R TGCAGAAGTGGGTTGTTTGC
OCT4 F GAAACCCACACTGCAGCAG
R GACCCAGCAGCCTCAAAATC
LIN28 F GGATGTCTTTGTGCACCAGAGTA
R TGGATTCCAGACCCTTGGCT
ALB F TGCCTGTTGCCAAAGCTCG
R GCTACTGCCCATGCTTTGAAAG
AFP F GCAAACGATGAAGCAAGAGTTTC
R GCAGCATTTCTCCAACAGGC
AAT F ACTGGAACCTATGATCTGAAGAGC
R GCCTTATGCACGGCCTTGG
CYP3A4 F GGATGAAAGAAAGTCGCCTCGA
R TCCAGATCGGACAGAGCTTTG
ACTB F CCTCGCCTTTGCCGATCC
R CATGCCGGAGCCGTTGT
States).
Colony formation assay
Primary and adherent AEC subpopulations were compared in a colony formation
assay. To collect the adherent AEC subpopulation, a selective primary passage was
used. This process was the same as the preculture step for the 3D culture, namely,
nonattached cells were removed after 72 h culture. Primary and adherent AECs were
seeded in a six-well plate at a density of 3000-20000 cells/well with AECBM. After 6 d
of incubation, the numbers of colonies containing > 20 cells were counted and traced
by scanning under an All-in-One Fluorescence Microscope (BZ-X710). The number of
colonies  was  divided  by  the  seeding  number  to  calculate  the  colony  formation
frequency.
Whole-transcriptome shotgun sequencing and bioinformatics analysis
Total RNA was extracted from primary AECs and RNA sequencing was performed
by  Eurofins  Genomics  K.K.  (Tokyo,  Japan)  who  used  the  Illumina  HiSeq  2500
(Illumina, San Diego, CA, United States).  Gene expression data for the other cell
sources  were  obtained from the  National  Center  for  Biotechnology Information
Sequence Read Archive (SRA) database (https://www.ncbi.nlm.nih.gov/sra). Data
sources are listed in Table 2.
RNA Sequencing. All paired-end reads were trimmed and quality-filtered via CLC
Genomics Workbench v. 10.1.1 (Qiagen, Hilden, Germany) which was also used to
map the filtered reads against the human reference sequence (hg 19). Mapped reads
were  counted  and transcript  abundance  was  measured  in  TPM (transcripts  per
kilobase million) units.
Bioinformatics  for  RNA Sequencing Data.  An original  read count  matrix  was
normalized with DESeq2 v. 3.5.2 for unified expression level. All normalized log-
transformed  expression  values  were  ordered  according  to  the  median  absolute
deviation. The top 3500 genes were selected for a heatmap which was generated with
the pheatmap package in R.
ICG test
AEC spheres or multiple stem cell-derived organoids were incubated with AECGM
and 1 mg/mL indocyanine green (ICG) (Daiichi Sankyo, Tokyo, Japan) for 30 min at
37  °C.  They  were  then  observed  under  bright  field  with  an  Inverted  System
Microscope IX71 to confirm ICG absorption. They were then incubated with ICG-free
AECGM for 6 h and checked for ICG elimination.
Statistical analysis
GraphPad Prism v. 8.0.1 (GraphPad Software, La Jolla, CA, United States) was used to
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Table 2  RNAseq data sources used in the bioinformatics analysis
Sample name SRA number Instrument Memo Ref.
AEC-1 SRR9643783 Illumina HiSeq 2500 Primary AEC
AEC-2 SRR9643784 Illumina HiSeq 2500 Primary AEC
MSC-1 SRR6431450 Illumina HiSeq 2000
[44]
MSC-2 SRR6431451 Illumina HiSeq 2000
[44]
hESC-1 SRR4241924 Illumina HiSeq 4000 H9
[45]
hESC-2 SRR4241926 Illumina HiSeq 4000 H9
[45]
NiPS-1 SRR7592168 Illumina HiSeq 2500 Normal human iPSC
[46]
NiPS-2 SRR7592169 Illumina HiSeq 2500 Normal human iPSC
[46]
DE-1 SRR771468 Illumina HiSeq 2000 Definitive endoderm induced from H9
[47]
DE-2 SRR771469 Illumina HiSeq 2000 Definitive endoderm induced from H9
[47]
hiHep-1 SRR5974291 Illumina HiSeq 2000 Umbilical cord fibroblast derived hepatocyte-like like cell
[8]
hiHep-2 SRR5974292 Illumina HiSeq 2000 Umbilical cord fibroblast derived hepatocyte-like cell
[8]
iPSCHLC-1 SRR5974295 Illumina HiSeq 2500 iPSC-derived Hepatocyte-like cell
[8]
iPSCHLC-2 SRR5974296 Illumina HiSeq 2500 iPSC-derived hepatocyte-like cell
[8]
Hepa-1 SRR6176953 Illumina HiSeq 2500 Hepatocyte from clinical sample of adult
[48]
Hepa-2 SRR6176948 Illumina HiSeq 2500 Hepatocyte from clinical sample of adult
[48]
Hepa-3 SRR5974298 Illumina HiSeq 2000 Primary human hepatocyte 2 d
[8]
Hepa-4 SRR5974299 Illumina HiSeq 2000 Primary human hepatocyte 4 d
[8]
process all  data.  A Wilcoxon signed-rank test  compared means between pairs of
groups. P < 0.05 was considered statistically significant.
RESULTS
Characterization of amnion-derived stem cells
The amnion consisted of monolayer epithelium and mesenchyme (Figure 1A). We
first examined the stemness characteristics of the amnion. Using an AP staining kit
(Muto  Pure  Chemicals,  Tokyo,  Japan),  we  found that  a  small  proportion  of  the
epithelial cells were blue (Figure 1B). AP is often used as a multipotency marker.
Immunofluorescence  analysis  of  frozen  amnion  sections  (Figures  1C  and  1D)
indicated  that  its  epithelium  was  positive  for  the  stemness  markers  SSEA4,  E-
cadherin,  and EPCAM. However,  other stemness markers such as TRA-1-60 (not
shown) and TRA-1-81 were not detected. Previous studies[18,19] reported that a small
subpopulation of AEC expresses TRA-1-60 or TRA-1-81. We attempted live staining of
fresh amnion and found a low frequency of TRA-1-60-positive cells (Figure 1E). We
concluded that amniotic epithelium has certain stemness or multipotency markers
and only a subpopulation of its cells expresses stemness.
The AEC isolation method yielded 1-6 × 107 AECs with > 90% viability. We then
examined AEC morphology, colony formation capability, and stemness markers. We
seeded AECs into a plate and observed them by phase contrast microscopy (Figure
1F). Although only a few primary AECs attached to the plate as short, spindle-like
cells  within  1  d,  they  proliferated  well  and  formed colonies.  After  the  primary
selective passage, the colony formation capacity increased ten-fold relative to that for
the heterogenous primary AECs (Figure 1G). We also verified the gene expression of
stemness  markers  by  qRT-PCR.  OCT4,  NANOG,  SOX2,  and  LIN28,  which  are
important iPSC markers, were expressed at very low levels in AECs compared with
those in iPSCs but at higher levels than those in MSCs (Figure 1H). We also analyzed
the stemness surface markers by flow cytometry (Figure 1I). E-cadherin and EPCAM
expression was highly positive. Certain SSEA4s were highly positive while others
were only weakly positive. Only 10% of the TRA-1-81 and TRA-1-60 were positive.
Based on the foregoing information,  we concluded that  amnion and AECs have
stemness and amniotic stem cells widely express stemness markers.
Hepatic potentials and profiling by whole-transcriptome shotgun sequencing
According to previous reports, AECs can differentiate into hepatocytes[20,21]. Here, we
performed comprehensive profiling by whole-transcriptome shotgun sequencing to
verify this potential in AECs. We also compared the AEC RNA sequences with those
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of pluripotent stem cells, hepatocytes or induced hepatocytes, and MSCs. MSCs are
also often used as hepatocyte cell sources[9]. First, we normalized the data and checked
its repeatability using Pearson’s correlation coefficient (Supplementary Figures 2A
and 2B). A principal component analysis (PCA) and a general heatmap (Figures 2A
and 2B) indicated that  AECs and MSCs differ  across the spectrum ranging from
pluripotent stem cells to hepatocytes. Even human fibroblast-derived hepatocyte-like
cells  (hiHep)  and  iPSC-derived  hepatocyte-like  cells  (iPSCHLCs),  which  had
immature  hepatic  characteristics[8],  did  not  closely  resemble  hepatocytes.  An
unexpected finding was that AECs were like hiHep and iPSCHLCs. We gathered 40
stem cell- and 66 hepatic cell markers to make a heatmap (Figure 2C). CD9 and TJP1
were highly expressed in both AECs and ESCs. IGF2BP2  and KRT19  were highly
expressed in both AECs and the definitive endoderm. The hepatic markers MET,
ABCC2, CYP1A1, etc. were highly expressed in AECs. The markers expressed in AECs
are  listed  in  Table  3.  The  features  common to  AEC,  pluripotent  stem cells,  and
hepatocytes may help elucidate the differentiation mechanism.
Hepatic differential induction with a 3D culture system
To induce hepatic differentiation, we raised AECs under a hepatic differentiation
protocol  and  a  3D  culture  system  (Figure  3A).  First,  we  tested  the  hepatic
differentiation  protocol  in  2D  culture.  We  attempted  a  two-step  differentiation
protocol using AECBM as a negative control. In the 2D culture, the AECs were short-
lived.  Nearly  all  the  cells  were  detached  from  the  culture  plate  within  3  wk.
Moreover,  gene expression did not  markedly increase during the culture period
(Supplementary Figure 3).
We then tried 3D culture with three protocols including the two-step, multistep,
and AECBM. With a 3D culture system in a micropattern plate,  the seeded cells
readily aggregated into a sphere and remained viable for 3 wk. We then checked
hepatic gene expression by qRT-PCR. Relative to the multistep and AECBM protocols,
hepatic gene expression in the two-step group protocol was higher (Figure 3B and
Supplementary Figure 4). ALB and CYP3A4 were upregulated and sustained for 3 wk.
Although AFP was upregulated in the 2D preculture then downregulated after 7 d, it
gradually  increased again within the 3-wk differentiation period.  AAT  was also
upregulated over 14 d but was downregulated by 21 d. When we seeded the AEC
sphere in a culture plate, we observed active AEC proliferation (Figure 3C). Based on
the preceding data, we concluded that our 3D cultural system maintains AEC viability
for > 3 wk and accelerates hepatic differentiation especially when a two-step protocol
is used.
Hepatic function enhancement with multicellular organoids
We then attempted co-culture by seeding AEC with MSC and HUVEC to form a
multicellular sphere organoid. We examined its morphology, cellular distribution,
and functional activity. Hematoxylin and eosin (H and E) staining disclosed that the
AEC sphere and the organoid were morphologically similar (Figure 4A). However,
immunofluorescence with CD31, CD90, SSEA4, and DAPI revealed inner-layer CD31-
positive HUVECs (data not shown) and CD90-positive MSCs as well as outer-layer
SSEA4-positive  AECs  (Figure  4B).  This  architecture  resembles  normal  tissue
disposition. Periodic acid Schiff staining showed glycogen accumulation in the center
of the organoid (Figure 4C). Both the AEC sphere and the organoid absorbed ICG but
only the organoid could excrete it (Figure 4D). From the aforementioned results, we
concluded that AECs, MSCs, and HUVECs underwent 3D construction in our 3D co-
culture system. Moreover, the organoid resembled a liver bud with complex liver
function.
DISCUSSION
AEC characteristics and stemness
AECs proliferate well and express stemness markers[20]. They also readily differentiate
into hepatocyte-like cells in the presence of certain growth factors[14].  Miki et al[20]
reported that AECs are derived from epiblasts and some of them remain immature
then differentiate into three germ layers[18,20,22]. Amnion immunofluorescence disclosed
that only a small proportion of AECs are TRA-1-81- and/or TRA-1-60-positive[19].
Here, it was confirmed by flow cytometry that a small primary AEC subpopulation is
TRA-1-60- and/or TRA-1-81-positive and the proportions vary among samples. Izumi
et al[18] reported that this subpopulation frequency is higher in early-stage than full-
term pregnancies. However, all AECs used in the present study were derived from
term pregnancies. Moreover, certain AEC lots with comparatively higher proportions
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Figure 2
Figure 2  Characteristics of primary amniotic epithelial cells and other cell sources verified by bioinformatics. A: Principal component analysis of all cell
sources used in this assay; B: General heatmap for each cell source; C: Specific heatmap of stemness and hepatic markers. AEC: Amniotic epithelial cell; Hepa:
Hepatocyte; hiHep: Human fibroblast-derived hepatocyte-like cell; MSC: Mesenchymal stem cell; DE: Definitive endoderm; hESC: Human embryonic stem cell;
iPSCHLC, iPSC-derived hepatocyte-like cell; NiPS: Normal human iPSC.
of these stem markers had high colony formation frequencies and grew well. For this
reason, it is important to select good AEC lots for differentiation.
Previous studies reported that primary AECs could be classified into three different
culture layers, namely, floating, attached, or intermediate[20]. In the present study, we
found that adherent cells derived from selective passage of primary AECs had a
comparatively high colony formation capability. Based on the foregoing information,
adherent  subpopulations  of  passaged  AECs  were  used  in  the  3D  culture.
Differentiation  efficiency  could  be  enhanced  by  purifying  this  high-stemness
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Table 3  Stemness (upper)- and hepatic (lower) genes expressed in amniotic epithelial cells.
Gene symbol Explanation Ref.
CD9 CD9 belongs to the transmembrane 4 superfamily.
It is associated with cell proliferation, motility, and
adhesion and regulates hematopoietic
differentiation
[49]
TJP1 Tight junction protein 1 is a determinant of plasma
cell proteasome and is associated with EGFR,
JAK1, and STAT3. It is regulated by TGF-b and
involved with cell motility
[30,50]
IGF2BP2 This member of the insulin–like growth factor 2
mRNA-binding protein family participates in
normal embryonic growth and development. It is
expressed in the pancreas and associated with
type 2 diabetes mellitus
[51]
KRT19 Keratin 19 is a cytoplasmic intermediate filament
protein and belongs to the type 1 keratin family. It
is used as a cholangiocyte marker and is not
expressed in hepatocytes. It is associated with the
progression of several cancers
[31,32]
GRB7 Growth factor receptor-bound protein 7 mediates
signal transduction and cell migration. It is
associated with the metastasis of several cancers
[52]
KRT8 Keratin 8 is a cytoplasmic intermediate filament
protein of the type 2 keratin family. It is expressed
in single layered epithelial cells. In cancer cells, it
is associated with progression in the form of
migration and adhesion
[33]
Gene symbol Explanation Ref.
ApoM Apolipoprotein M (apoM) belongs to the lipocalin
family. It is expressed in the liver and kidney.
Hepatic apoM controls HDL metabolism
[53,54]
CPS1 Carbamoyl phosphate synthase 1 is a
mitochondrial enzyme and participates in the first
step of the urea cycle in the liver.
[55]
SLC51A Organic solute transporter subunit alpha is a bile
acid transporter in the liver, small intestine, and
kidney. It prevents the bile acid reflux
[56]
IL6ST Interleukin 6 signal transducer controls IL-6 and
other cytokines such as IL-11, IL-27, oncostatin M,
and leukemia inhibitory factor
[57]
ACOX1 Acyl-CoA oxidase 1 is a rate-limiting enzyme in
fatty acid β-oxidation
[58]
RXRa The nuclear hormone receptor retinoid X receptor
belongs to the steroid hormone receptor family. It
is a key factor of cholesterol synthesis
[59]
MET MET encodes the hepatocyte growth factor (HGF)
receptor and the key factor of hepatic
regeneration. It activates epithelial migration and
3D morphogenesis
[35,36]
ABCC2 ATP binding cassette subfamily C member 2 is
expressed in the hepatocytes and is a biliary
transporter. It is also related to drug elimination
and multidrug resistance in several cancers
[60]
CYP1A1 This member of the cytochrome P450 enzyme
superfamily participates in fatty acid and steroid
metabolism. It is associated with the detoxification
of anthropogenic chemicals such as polycyclic
aromatic hydrocarbons
[61]
subpopulation of primary AECs.
Hepatic differentiation protocol
The iPSC-derived organoids have often been considered as models  representing
organs with highly complex structures and/or functions such as the intestine, lung,
neural tissue, etc[23-25]. Cell-to-cell interactions[26] and hypoxic reactions were key factors
in differentiation[27]. In the case of hepatic differentiation from iPSCs, mesenchymal
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Figure 3
Figure 3  Characteristics of amniotic epithelial cell spheres formed on 3D-micropattern plate. A: 3D-micropattern plate used in the present study. Round pits
500 µm in diameter are clustered on the surface. After culture, the amniotic epithelial cells (AECs) formed a sphere; B: Gene expression in the AEC sphere verified by
qRT-PCR; C: After reseeding AEC sphere onto 2D culture dish, AEC proliferation was verified by phase-contrast microscopy. Bar, 500 µm.
and endothelial cells were reported as important factors[16]. However, only 2D culture
was used in the attempt to differentiate AECs into hepatocytes[14,28] and the protocol
used was not comparable to that applied in the present study.
Therefore, we compared 2D and 3D culture with several differentiation protocols.
The 2D culture method was unsuitable for AECs because the cells did not remain
viable in it. In 3D culture, AECs retain their viability and morphology for 21 d. A
previous report stated for an iPSCs’ hepatic differentiation model in a 3D culture
system that hypoxia suppresses cell proliferation and induces differentiation[26,27]. In
the present study, AEC sphere proliferation was temporarily arrested during 3D
culture  then  resumed  after  plate  seeding.  Therefore,  a  similar  mechanism  was
assumed to occur under our AEC 3D culture conditions.
To date,  no hepatic  differentiation protocol  has been established for  AECs.  In
certain  studies,  an  iPSC-to-hepatocyte  differentiation  protocol  was  used[15,29].
However, this stepwise protocol is complex and requires numerous growth factors.
Since AECs are not pluripotent stem cells, it is uncertain whether every protocol step
would be absolutely necessary. One report mentioned that activin A is not required
for hepatic differentiation from AECs[15]. Activin A is required for the transformation
of pluripotent stem cells to the definitive endodermal state. In contrast, the AEC-to-
hepatocyte differentiation protocol is comparatively simple[14]. Our results indicated
that this straightforward differentiation protocol upregulates AEC hepatic genes.
Nevertheless, it may still be inadequate and must, therefore, be modified. Despite this
deficiency, the co-culture method can nonetheless generate hepatic function from
AECs. We concluded that a 3D co-culture system or a hepatic microenvironment is
needed for hepatic differentiation from AECs.
Bioinformatics approach
Bioinformatics is a strong tool for the evaluation of cellular differentiation. It is often
applied to  iPSCs but  not  to  AECs.  Our PCA and general  heatmap revealed that
hiHep[8]  and iPSCHLCs[8]  remotely resemble mature hepatocytes. In fact, they are
regarded as immature hepatocytes. AECs and MSCs are distant from iPSCs, ESCs,
and DE but more closely resemble hiHep and iPSCHLCs. Therefore, AECs may be
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Figure 4
Figure 4  Organoid morphology and hepatic function. A and C: Frozen sections of amniotic epithelial cell (AEC) sphere and organoid. The AEC sphere was placed
in the upper layer and the organoid was placed in the lower layer. H&E staining is used in A, and Periodic acid Schiff staining is used in C; B: Immunofluorescent
organoid staining observed under confocal microscopy. Anti-SSEA4 antibody (green) representing AECs; anti-CD90 antibody (red) representing mesenchymal stem
cells and DAPI. Bars in A, B, and C, 50 µm; D: ICG tests on AEC sphere and organoid. The AEC sphere was placed in the upper layer and the organoid was placed in
the lower layer.
able to differentiate into hepatocytes in only a few steps.
The stemness and hepatic marker heatmaps disclosed certain genes common to all
AECs.  TJP1  is  associated with  EGFR/JAK1/STAT3 signaling[30].  Every two-step,
multistep, and AECBM protocol included EGF and seemed reasonable. KRT8  and
KRT19 are epidermal markers[31-33] and are also upregulated in AECs. In the hepatic
transdifferentiation from fibroblasts, the first step is to transform mesenchymal cells
into epidermal cells[34].  In the differentiation of  ESC to DE, KRT8  and KRT19  are
upregulated. Therefore, differentiation of AECs to hepatocytes may require fewer
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steps than pluripotent stem cell-to-hepatocyte differentiation.
The hepatic  marker  MET  was upregulated in  AECs.  MET  encodes the human
growth factor (HGF) receptor which is  important for hepatocyte proliferation or
differentiation[35,36].  HGF may already be sensitive in AECs.  In addition,  IL6ST  is
upregulated  in  AECs.  It  transduces  the  signals  of  several  chemicals  containing
oncostatin M. HGF and oncostatin M are normally added to iPSCs in the hepatocyte-
like cell protocol but not in our two-step protocol[6]. Therefore, we may be able to
improve differentiation by adding HGF or oncostatin M to our two-step protocol.
Moreover, other markers of hepatic metabolism may also enhance liver function. A
detailed  list  of  the  stemness  and  hepatic  genes  is  presented  in  Table  3  A
bioinformatics  approach  may help  elucidate  the  differentiation  mechanism and
improve the protocol used for it.
Future prospects
An  iPSC-derived  hepatic  organoid  has  already  been  created  and  used  in  basic
research ex vivo[17].  However,  iPSCs are costly,  unstable,  and tumorigenic[37,38].  In
contrast, our organoid is cost-effective, stable, and non-tumorigenic. AEC organoids
with  hepatic  character  could  be  used  both  in  basic  ex  vivo  research  and  in  vivo
experiments.
The  next  step  of  our  research  is  to  develop  and  test  a  human-to-animal
transplantation model with AEC-derived hepatic organoids. According to a previous
report, terminal differentiation to a functional hepatocyte would be strongly induced
in the recipient  liver  microenvironment[15].  Even in our  organoids simulated the
microenvironment,  the  process  would  not  be  as  perfect  as  it  would  be  in  vivo.
Therefore, in vitro tests of hepatic organoid function may be imperfect. Nevertheless,
we  must  confirm  hepatic  function  after  transplantation.  The  present  study
demonstrated that the 3D culture condition temporarily suppressed proliferation but
did not entirely cause a loss of this capability. Therefore, proliferation could still occur
in vivo with the appropriate signal. Human organoids and animal transplantation
models are required for pharmaceutical research and investigations into human-
specific infectious disease such as hepatitis B and C[17,39].
A future intended application of our hepatic organoid is as an alternative to organ
transplantation as a therapy for hepatic failure. More than one induction step from
somatic cells to iPSCs is required and quality and safety must be verified[40,41]. On the
other hand, AECs are directly isolated from tissues so they are comparatively safe and
reliable.
Safety is of paramount importance in the clinical application of organoids. In this
respect, AECs are superior to iPSCs. The safest transplantation model is a private
placental and cord blood cell bank. Preserved blood cells can be used as a replacement
therapy for hematopoietic disease and the regenerative treatment of congenital heart
diseases and other developmental disorders[42,43]. Amnion and umbilical cords also
have the same genetic profile as the baby. Therefore, private AEC, MSC, and HUVEC
cell  banks  could  be  ideal  sources  of  therapeutic  materials  for  infants  with
developmental conditions.
In conclusion, we selected adherent AECs in which ASCs were purified as a cell
source for differentiation into hepatocytes. The 3D- and co-culture systems with MSCs
and  HUVECs  generated  multicellular  organoids  with  hepatic  function.  A
bioinformatics  approach  and cell  selection  strategy  would  be  useful  for  further
improvement of the protocol and its hepatic function.
ARTICLE HIGHLIGHTS
Research background
Cell transplantation is a promising method to solve the problem of organ donor deficiency.
Recently, amniotic epithelial cells (AECs) have been studied as a somatic stem cell source for
regenerative medicine. It has been reported that AECs possess hepatic differentiation capability
and they are more cost-effective and non-tumorigenic compared to other cell types. Therefore,
AECs could provide a new cell source for cell transplantation in the future, particularly for liver
diseases.
Research motivation
However, the general profile for AECs has not been comprehensively analyzed and hepatic
differentiation protocol for AECs has also not been established. Therefore, by clarifying the
comprehensive characteristics of AECs and refining the hepatic differentiation protocol, we
could use it effectively as a transplantation cell source in the future.
Research objectives
This  study  aimed  to  elucidate  the  comprehensive  characteristics  of  human  AECs,  and  to
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establish  a  novel  hepatic  differentiation  protocol.  Additionally,  3D  multicellular  culture
condition and purification of stem cells obtained from AECs were studied, with an intention to
improve their differentiation capability.
Research methods
All examined AECs, mesenchymal stem cells (MSCs), and human umbilical vein endothelial cells
(HUVECs) were isolated from the placentae and umbilical cords after cesarean section. Stemness
characteristics  and  heterogeneity  of  amnion  and  primary  AECs  were  analyzed  by
immunofluorescence and AP staining, and flow cytometry. In addition, AEC transcriptomes
were analyzed and compared with those for other cell sources based on bioinformatics. An
adherent AEC subpopulation was selected from primary isolated AECs and their amniotic stem
cell  (ASC) purification quality  was evaluated based on a  colony formation assay.  Hepatic
differentiation capacities of AECs which were cultured in varying 2D or 3D conditions were
compared according to their relative gene expression. Finally, ASCs, MSCs and HUVECs were
co-cultured in a 3D system to generate hepatic organoids, and the organoid structure and hepatic
function were compared with those of 3D AEC spheres using immunofluorescence imaging,
Periodic acid Schiff staining, and an indocyanine green (ICG) test.
Research results
AECs expressed stemness markers such as EPCAM, SSEA4,  and E-cadherin,  whereas only
limited cells in the AEC subpopulation were AP-positive, or expressed TRA-1-60 and TRA-1-81
stemness marker in the  flow cytometry. The colony formation assay revealed that primary AECs
could form colonies and the frequency was enhanced ten-fold in the adherent subpopulation.
According to bioinformatics analysis of RNA sequencing, the primary AEC gene expression was
different from those of pluripotent stem cells and hepatocytes; however, some overlapped genes
were detected. Compared with the 2D system, AECs could retain their viability for a longer time
in 3D culture conditions and the hepatic gene expressions were comparatively elevated using a
two-step differentiation protocol. Furthermore, organoids derived from 3D multicellular culture
condition  using  ASCs,  MSCs  and HUVECs,  showed a  3D hepatic  structure  with  polarity,
hepatic-like glycogen storage, and ICG absorption/elimination.
Research conclusions
Human AECs  are  heterogeneous  and certain  subpopulations  exhibit  high  stemness.  AEC
transcriptome analysis suggests some advantages and factors related to hepatic differentiation.
3D multicellular culture conditions improve the differentiation of ASCs into functional hepatic
organoids.
Research perspectives
The results of this comprehensive analysis indicate that AECs have high hepatic differentiation
capability which should be optimized. By optimizing the selected high stemness subpopulations
of AECs and using a 3D co-culture system, AEC-derived hepatic organoid can be used for
performing transplantation experiments to evaluate its in vivo function.
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